EODData

FRA, AYJ0: VALNEVA SE SP.ADS/2

05 Nov 2025
LAST:

7.550

CHANGE:
 0.30
OPEN:
7.000
HIGH:
7.550
ASK:
0.000
VOLUME:
350
CHG(%):
3.82
PREV:
7.850
LOW:
7.000
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 257.0007.5507.0007.550350
04 Nov 257.0007.8507.0007.850350
03 Nov 258.2508.2508.2508.250350
31 Oct 257.0508.4007.0507.850160
30 Oct 257.0007.8007.0007.50013
29 Oct 256.9507.8506.9507.60013
28 Oct 257.0507.7507.0507.500650
27 Oct 257.2007.9007.2007.650650
24 Oct 257.4008.0007.3008.000650
23 Oct 257.2508.1007.2508.100650

COMPANY PROFILE

Name:VALNEVA SE SP.ADS/2
About:Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France.
Sector:Healthcare
Industry:Biotechnology
Address:6 rue Alain Bombard, Saint-Herblain, France, 44800
Website:https://valneva.com
ISIN:US92025Y1038

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:63.89 
Forward P/E:-14.54 
PEG Ratio:-14.54 
Price to Sales:3.49 
Price to Book:7.01 
Profit Margin:-0.34 
Operating Margin:-0.22 
Return on Assets:-0.07 
Return on Equity:-0.38 
Revenue:196.33M 
EBITDA:35.01M 
Shares:85.03M 
Market Cap:641.99M 

TECHNICAL INDICATORS

MA5:7.803.3%
MA10:7.793.1%
MA20:8.188.3%
MA50:8.158.0%
MA100:7.145.7%
MA200:6.5116.0%
STO9:5.56 
STO14:3.85 
RSI14:44.29
WPR14:-95.45 
MTM14:-1.05
ROC14:-0.12 
ATR:0.89 
Week High:8.4011.3%
Week Low:6.958.6%
Month High:9.5526.5%
Month Low:6.9516.0%
Year High:10.5039.1%
Year Low:3.30128.9%
Volatility:67.46